Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kriti Pallavi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cancer Research and Therapeutics|December 13, 2022
Histopathological prognosticators and their clinicopathological correlation in oral squamous cell carcinomas of the tongueKriti Pallavi, Ankita Tandon, Nikita Gulati, et al.
Indian Journal of Pathology & Microbiology|June 17, 2024
Neuroectodermal influence in odontogenic cyst and tumor: Evidence through CD56 immunoexpressionKriti Pallavi, Anshi Jain, Nikita Gulati, et al.
Trials|April 18, 2026
Randomized, double-blind, placebo-controlled study of oral duloxetine in prevention of acute pain syndrome in breast cancer patients receiving paclitaxel (DOPA study)Jahnavi Banotra, Vrajesh Veenadhar Shetty, Sameer Bakhshi, et al.
Frontiers in Pharmacology|March 9, 2026
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH studyHemavathi Baskarane, Mohit Kumar Divakar, Akhil P Santhosh, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cancer Research and Therapeutics|December 13, 2022
Histopathological prognosticators and their clinicopathological correlation in oral squamous cell carcinomas of the tongueKriti Pallavi, Ankita Tandon, Nikita Gulati, et al.
Indian Journal of Pathology & Microbiology|June 17, 2024
Neuroectodermal influence in odontogenic cyst and tumor: Evidence through CD56 immunoexpressionKriti Pallavi, Anshi Jain, Nikita Gulati, et al.
Trials|April 18, 2026
Randomized, double-blind, placebo-controlled study of oral duloxetine in prevention of acute pain syndrome in breast cancer patients receiving paclitaxel (DOPA study)Jahnavi Banotra, Vrajesh Veenadhar Shetty, Sameer Bakhshi, et al.
Frontiers in Pharmacology|March 9, 2026
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH studyHemavathi Baskarane, Mohit Kumar Divakar, Akhil P Santhosh, et al.
Pageof 1